assay
>99% (HPLC/MS)
form
solution
packaging
pkg of 1 × 5 mL (300116S-1EA)
manufacturer/tradename
Avanti Research™ - A Croda Brand
application(s)
vaccine development
shipped in
dry ice
storage temp.
−20°C
General description
Formulation: A Pegylated, long-circulating liposomal formulation with an ammonium sulfate core. Liposomes are stored frozen for a longer shelf life.
Application
Control (5mL vial) has been used as a control for doxorubicin Hcl product (Dox2) to study its characteristics by asymmetrical-flow field flow fractionation (MD-AF4). It may be used as a vehicle control liposome for liposomal encapsulated doxorubicin (Dox-NP).
Packaging
10 mL clear serum vial (300116S-1EA)
Legal Information
Avanti Research is a trademark of Avanti Polar Lipids, LLC
存储类别
12 - Non Combustible Liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Physical characterization of liposomal drug formulations using multi-detector asymmetrical-flow field flow fractionation
Parot J, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society (2020)
J Parot et al.
Journal of controlled release : official journal of the Controlled Release Society, 320, 495-510 (2020-02-01)
Liposomal formulations for the treatment of cancer and other diseases are the most common form of nanotechnology enabled pharmaceuticals (NEPs) submitted for market approval and in clinical application today. The accurate characterization of their physical-chemical properties is a key requirement;
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持